Rosuvastatin Given During Reperfusion Decreases Infarct Size and Inhibits Matrix Metalloproteinase-2 Activity in Normocholesterolemic and Hypercholesterolemic Rabbits-Reference-Cited by-同舟云学术

Rosuvastatin Given During Reperfusion Decreases Infarct Size and Inhibits Matrix Metalloproteinase-2 Activity in Normocholesterolemic and Hypercholesterolemic Rabbits

Published:2009-02 Issue:2 Volume:53 Page:137-144
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

D'Annunzio Verónica,Donato Martín,Erni Lukas,Miksztowicz Verónica,Buchholz Bruno,Carrión Cristina Lorenzo,Schreier Laura,Wikinski Regina,Gelpi Ricardo J,Berg Gabriela,Basso Nidia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference40 articles.

1. Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins.;Pearson;Am J Cardiol,1998

2. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.;Pedersen;Arch Intern Med,1996

3. Statins and their role in vascular protection.;Mason;Clin Sci (Lond),2003

4. Current perspectives on statins.;Maron;Circulation,2000

5. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors.;Laufs;Circulation,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of temporal changes of pro-inflammatory cytokines in the development of adverse cardiac remodeling after ST-elevation myocardial infarction;Advances in Interventional Cardiology;2022

2. Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors;International Journal of Molecular Sciences;2020-09-23

3. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore;Journal of Physiology and Biochemistry;2020-01-08

4. Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection;Frontiers in Pharmacology;2018-04-05

5. Daño por isquemia-reperfusión miocárdico en cirugía cardiaca con circulación extracorpórea. Aspectos bioquímicos;Cirugía Cardiovascular;2018-03